Parian Global Management logo

Parian Global Management

North America, New York, United States, New York

Description

Parian Global Management is an investment firm that seeks to invest in dynamic industries.

Investor Profile

Parian Global Management has made 4 investments, with 0 in the past 12 months and 25% as lead.

Stage Focus

  • Series E (50%)
  • Series D (25%)
  • Series C (25%)

Country Focus

  • United States (75%)
  • The Netherlands (25%)

Industry Focus

  • Health Care
  • Medical Device
  • Health Diagnostics
  • Biotechnology
  • Life Science
  • Medical
  • Mobile
  • Oncology
  • Personal Health
  • Hospital
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Parian Global Management frequently co-invest with?

Irving Investors
North America, Colorado, United States, Denver
Co-Investments: 1
OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Farallon Capital Management
North America, California, United States, San Francisco
Co-Investments: 1
Alta Life Sciences
Europe, Catalonia, Spain, Barcelona
Co-Investments: 1
Johnson & Johnson Development Corporation
North America, New Jersey, United States, New Brunswick
Co-Investments: 1
ArrowMark Partners
North America, Colorado, United States, Denver
Co-Investments: 1
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Gilde Healthcare
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 1
Lauxera Capital Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Hildred Capital Partners
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Parian Global Management?

Binx Health

Boston, Massachusetts, United States

Binx Health is a healthcare technology company that makes testing more convenient and accessible to individuals.

Health CareHealth DiagnosticsMedical DeviceMobile
Series EMay 27, 2021
Amount Raised: $104,000,000
Sera Prognostics

Salt Lake City, Utah, United States

Sera Prognostics develops blood tests that are predictive of preterm birth, preeclampsia, and other pregnancy complications.

BiotechnologyHealth CareHospitalMedicalMedical Device
Series EApr 28, 2021
Amount Raised: $100,000,000
Renovia

Boston, Massachusetts, United States

Renovia was a developer of prescription digital therapeutics for pelvic floor disorders. Renovia ceased operations in late 2022.

Health CareHealth DiagnosticsLife ScienceMedicalPersonal Health
Series CApr 19, 2021
Amount Raised: $17,000,000
LUMICKS

Amsterdam, Noord-Holland, The Netherlands

LUMICKS provides single-molecule analysis technologies for cancer research and immunotherapy.

BiotechnologyLife ScienceMedical DeviceOncology
Series DApr 16, 2021
Amount Raised: $92,983,017